- 0 Anmeldelser
- 0
- Afsnit
- 1158 of 1563
- Længde
- 12M
- Sprog
- Engelsk
- Format
- Kategori
- Fakta
For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it causes brutal side effects for others. An antipsychotic drug approved last month by the FDA changes that. It triggers muscarinic receptors instead of dopamine receptors. The drug is the result of a chance scientific finding ... from a study that wasn't even focused on schizophrenia. Host Emily Kwong and NPR pharmaceutical correspondent Sydney Lupkin dive into where the drug originated, how it works and what it might shift for people with schizophrenia.
Read more of Sydney's reporting.
Curious about other drug treatments in the news? Email us at shortwave@npr.org and we might cover your topic on a future episode!
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Other podcasts you might like ...
- M’usa, con l’apostrofo. Le donne di PicassoLetizia Bravi
- FC PopCornFilm Companion
- Do I Like It?The Quint
- The Big StoryThe Quint
- DiskoteksbrandenAntonio de la Cruz
- Dragon gateEdith Söderström
- En amerikansk epidemiPatrick Stanelius
- En värld i brand: Andra världskriget och sanningenAnton Vretander
- FamiljenFrida Anund
- Hagen-fallet: Spårlöst försvunnenAntonio de la Cruz
- M’usa, con l’apostrofo. Le donne di PicassoLetizia Bravi
- FC PopCornFilm Companion
- Do I Like It?The Quint
- The Big StoryThe Quint
- DiskoteksbrandenAntonio de la Cruz
- Dragon gateEdith Söderström
- En amerikansk epidemiPatrick Stanelius
- En värld i brand: Andra världskriget och sanningenAnton Vretander
- FamiljenFrida Anund
- Hagen-fallet: Spårlöst försvunnenAntonio de la Cruz
